Prebiotics and Probiotics: Therapeutic Tools for Nonalcoholic Fatty Liver Disease
Open Access
- 5 October 2023
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 24 (19) , 14918
Abstract
Alterations in the gut–liver axis and changes in the gut microbiome are among the risk factors for the pathogenesis of non-alcoholic fatty liver disease (NAFLD). These patients show increased bacterial overgrowth in the small intestine and impaired intestinal permeability. Therefore, therapeutic options such as probiotics or prebiotics have been investigated to modulate intestinal microbiota composition to improve NAFLD. Most in vivo and in vitro probiotic studies have focused on reducing hepatic fat accumulation. The beneficial effects of probiotics on NAFLD have been demonstrated in animal models, and the most widely used microorganisms are those of the Lactobacillus and Bifidobacterium genera. In animal models, probiotics help restore the intestinal microbiota and improve the integrity of the intestinal barrier. This narrative review summarizes published evidence and the likely benefits of probiotics and prebiotics as a therapeutic option for patients with NAFLD.Keywords
Funding Information
- Medica Sur Clinic and Foundation
This publication has 73 references indexed in Scilit:
- Gut-Liver Axis, Gut Microbiota, and Its Modulation in the Management of Liver Diseases: A Review of the LiteratureInternational Journal of Molecular Sciences, 2019
- Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trialEuropean Journal of Nutrition, 2018
- Probiotics may delay the progression of nonalcoholic fatty liver disease by restoring the gut microbiota structure and improving intestinal endotoxemiaScientific Reports, 2017
- Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease preventionBMC Gastroenterology, 2016
- Cholesterol Assimilation byLactobacillusProbiotic Bacteria: AnIn VitroInvestigationBioMed Research International, 2014
- Cholesterol-lowering probiotics: in vitro selection and in vivo testing of bifidobacteriaApplied Microbiology and Biotechnology, 2013
- Butyrate-Producing Probiotics Reduce Nonalcoholic Fatty Liver Disease Progression in Rats: New Insight into the Probiotics for the Gut-Liver AxisPLOS ONE, 2013
- In vitro testing of commercial and potential probiotic lactic acid bacteriaInternational Journal of Food Microbiology, 2012
- Probiotics as an emerging therapeutic strategy to treat NAFLD: focus on molecular and biochemical mechanismsThe Journal of Nutritional Biochemistry, 2011
- An In Vitro Study of the Probiotic Potential of a Bile-Salt-Hydrolyzing Lactobacillus fermentum Strain, and Determination of Its Cholesterol-Lowering PropertiesApplied and Environmental Microbiology, 2003